Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Beck

Showing results (111-120 of 181) with videos related to

Pageof 19
Sort By:
The Journal of Spinal Cord Medicine|August 22, 2024
Functional outcomes and participants' perspectives during short-term application of spinal stimulation in individuals with spinal cord injuryDaniel D Veith, Megan L Gill, Lisa A Beck, et al.
Clinical and Translational Allergy|March 28, 2023
Developing integrated care pathways for atopic dermatitis-Challenges and unmet needsTorsten Zuberbier, Lisa A Beck, Anna Bedbrook, et al.
The Journal of Investigative Dermatology|November 25, 2011
Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticumPei-Song Gao, Donald Y M Leung, Nicholas M Rafaels, et al.
NPJ Digital Medicine|March 4, 2021
Development of digital measures for nighttime scratch and sleep using wrist-worn wearable devicesNikhil Mahadevan, Yiorgos Christakis, Junrui Di, et al.
American Journal of Clinical Dermatology|May 3, 2022
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic DermatitisLisa A Beck, Mette Deleuran, Robert Bissonnette, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2009
Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticumPei-Song Gao, Nicholas M Rafaels, Tracey Hand, et al.
The Journal of Investigative Dermatology|December 11, 2012
Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repairI-Hsin Kuo, Amanda Carpenter-Mendini, Takeshi Yoshida, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2023
At-Home High-Intensity Interval Training for Individuals with Paraplegia Following Spinal Cord Injury: A Pilot StudyMargaux B Linde, Kevin L Webb, Daniel D Veith, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2023
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trialEmma Guttman-Yassky, Jonathan I Silverberg, Diamant Thaçi, et al.
Journal of Physical Medicine and Rehabilitation (Wilmington, Del.)|March 11, 2026
At-Home High-Intensity Interval Training for Individuals with Paraplegia Following Spinal Cord Injury: A Case SeriesKevin L Webb, Margaux B Linde, Daniel D Veith, et al.
Pageof 19

Showing results (111-120 of 181) with videos related to

Sort By:
Pageof 19
The Journal of Spinal Cord Medicine|August 22, 2024
Functional outcomes and participants' perspectives during short-term application of spinal stimulation in individuals with spinal cord injuryDaniel D Veith, Megan L Gill, Lisa A Beck, et al.
Clinical and Translational Allergy|March 28, 2023
Developing integrated care pathways for atopic dermatitis-Challenges and unmet needsTorsten Zuberbier, Lisa A Beck, Anna Bedbrook, et al.
The Journal of Investigative Dermatology|November 25, 2011
Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticumPei-Song Gao, Donald Y M Leung, Nicholas M Rafaels, et al.
NPJ Digital Medicine|March 4, 2021
Development of digital measures for nighttime scratch and sleep using wrist-worn wearable devicesNikhil Mahadevan, Yiorgos Christakis, Junrui Di, et al.
American Journal of Clinical Dermatology|May 3, 2022
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic DermatitisLisa A Beck, Mette Deleuran, Robert Bissonnette, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2009
Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticumPei-Song Gao, Nicholas M Rafaels, Tracey Hand, et al.
The Journal of Investigative Dermatology|December 11, 2012
Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repairI-Hsin Kuo, Amanda Carpenter-Mendini, Takeshi Yoshida, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2023
At-Home High-Intensity Interval Training for Individuals with Paraplegia Following Spinal Cord Injury: A Pilot StudyMargaux B Linde, Kevin L Webb, Daniel D Veith, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2023
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trialEmma Guttman-Yassky, Jonathan I Silverberg, Diamant Thaçi, et al.
Journal of Physical Medicine and Rehabilitation (Wilmington, Del.)|March 11, 2026
At-Home High-Intensity Interval Training for Individuals with Paraplegia Following Spinal Cord Injury: A Case SeriesKevin L Webb, Margaux B Linde, Daniel D Veith, et al.
Pageof 19